Warning
Apotex Corp. Recalls Desmopressin Nasal Spray
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0510-2026Drug / Pharmaceutical
Apotex Corp. Recalls Desmopressin Nasal Spray
Apotex Corp. · Class II — Moderate Risk
Product Description
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Reason for Recall
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S.A. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Apotex Corp. initiated the recall on April 8, 2026. Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. The product was distributed in U.S.A. Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Apotex Corp. for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.